Ryesino Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Uttar Pradesh, Uttar Pradesh, India, established in 1983.
1983 Uttar Pradesh, Uttar Pradesh, India Active
Last Updated:
Access Report
About Ryesino Pharmaceuticals Private Limited

Ryesino Pharmaceuticals Private Limited, a active private limited company, was established on 15 December 1983 in Uttar Pradesh, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85110UP1983PTC006356. Registered under ROC Roc Uttar Pradesh I. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.83 M.

It upholds a compliant status. Its leadership includes Jaidesh Pal Wason (Managing Director), Renu Wason (Director), Sachin Wason (Director). Past directors included Tarun Wason, Meena Wason, Suresh Kumar Wason. It holds ₹7.65 M open charges and ₹9.50 M settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 3 B Race Course Dehradun, Uttar Pradesh, Uttar Pradesh, 248001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110UP1983PTC006356

  • Registration Number

    006356

  • Incorporation Date

    15 December 1983

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.83 M

  • ROC Code

    Roc Uttar Pradesh I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.83 M
  • Company Age 42 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.65 M
  • Satisfied Charges ₹ 9.50 M
  • Revenue Growth **** 6.50%
  • Profit Growth **** -1.77%
  • Ebitda **** -71.34%
  • Net Worth 22.32%
  • Total Assets **** 44.37%
Company report

Ryesino Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ryesino Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ryesino Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jaidesh Pal Wason Managing Director 15 Dec 1983 Current
Renu Wason Director 18 Dec 1986 Current
Sachin Wason Director 27 Mar 2000 Current
Shagun Wason Director 01 Jun 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Apr 2019 Past
Pramod Abcsdd Director 15 Apr 2019 Past
Pramod Abcsdd Director 15 Apr 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ryesino Pharmaceuticals.

Ryesino Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.5% increase. The company also saw a slight decrease in profitability, with a 1.77% decrease in profit. The company's net worth Soared by an impressive increase of 22.32%.

Ryesino Pharmaceuticals revenue growth over time
Ryesino Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 6.50%
*******
*******
*******
*******
Revenue from Operations
*******
 6.50%
*******
*******
*******
*******
Total Assets
*******
 44.37%
*******
*******
*******
*******
Profit or Loss
*******
 -1.77%
*******
*******
*******
*******
Net Worth
*******
 22.32%
*******
*******
*******
*******
EBITDA
*******
 -71.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ryesino Pharmaceuticals?

Unlock access to Ryesino Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,645,000.00

Satisfied Charges

₹9,500,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.65 Cr
  • Others : 0.12 Cr
Latest Charge Details
Date Lender Amount Status
20 Aug 2025 Others ₹1.20 M Open
18 Nov 2005 State Bank Of India ₹6.00 M Open
08 Sep 2000 State Bank Of India ₹0.45 M Open
22 May 2007 State Bank Of India ₹9.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ryesino Pharmaceuticals?

Unlock and access historical data on people associated with Ryesino Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ryesino Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ryesino Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ryesino Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ryesino Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.

  • Charges

    A charge with Others amounted to Rs. 1.20 M with Charge ID 101155673 was registered on 20 Aug 2025. was recorded as a recent event.

  • Balance Sheet

    The activity Ryesino Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I. was completed.

  • Charges

    Progress on A charge registered on 22 May 2007 via Charge ID 10053997 with State Bank Of India was fully satisfied on 17 Aug 2023. was documented.

  • Charges

    A charge with State Bank Of India of Rs. 9.50 M registered on 22 May 2007 with Charge ID 10053997 was modified on 18 Sep 2014. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India amounted to Rs. 9.50 M with Charge ID 10053997 was registered on 22 May 2007. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ryesino Pharmaceuticals Private Limited?

The CIN of Ryesino Pharmaceuticals Private Limited is U85110UP1983PTC006356.

Where is Ryesino Pharmaceuticals Private Limited headquartered?

Ryesino Pharmaceuticals Private Limited is headquartered at 3 B Race Course Dehradun, Uttar Pradesh, Uttar Pradesh, 248001.

When was Ryesino Pharmaceuticals Private Limited incorporated?

Ryesino Pharmaceuticals Private Limited was incorporated on 15 December 1983.

Who are the current directors of Ryesino Pharmaceuticals Private Limited?

The current directors of Ryesino Pharmaceuticals Private Limited are

What is the primary industry of Ryesino Pharmaceuticals Private Limited?

The primary industry of Ryesino Pharmaceuticals Private Limited is Trade.

Is Ryesino Pharmaceuticals Private Limited a listed company?

Ryesino Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ryesino Pharmaceuticals Private Limited?

The authorized capital of Ryesino Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.83 M.

What is the compliance status of Ryesino Pharmaceuticals Private Limited?

The compliance status of Ryesino Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available